investors
Press Release
-
22
Hudson Therapeutics, the U.S. Subsidiary of Shaperon, Announces Initiation of Phase 2b Part 2 Clinical Trial for Nugel
-
Posted on
2025-03-05
-
Views
203
-
-
21
Hudson Therapeutics, Inc. and Shaperon, Inc. to Participate in Leading Major Global Partnering and Investor Biotech Conferences at the JP Morgan Healthcare Conference Week, January 12-16, 2025, in San Francisco
-
Posted on
2024-12-29
-
Views
112
-
-
20
Hudson Therapeutics, Inc. and Shaperon, Inc. to Participate in Leading Major Global Partnering and Investor Biotech Conferences at the JP Morgan Healthcare Conference Week, January 12-16, 2025, in San Francisco
-
Posted on
2024-12-09
-
Views
81
-
-
19
Shaperon Wins ‘2024 Korea CEO Hall of Fame’ Award for Third Consecutive Year, Recognized for Innovation in Atopic Dermatitis
-
Posted on
2024-10-28
-
Views
97
-
-
18
[NEWS CLIPPING] SHAPERON, THE POSSIBILITY OF EXPORTING NUGEL
-
Posted on
2024-09-25
-
Views
79
-
-
17
[NEWS CLIPPING] SHAPERON, ATOPIC DERM. SAFE IN US PHASE 2 TRIAL
-
Posted on
2024-09-11
-
Views
96
-
-
16
PARTICIPATION AT CHINABIO® PARTNERING FORUM
-
Posted on
2024-09-11
-
Views
75
-
-
15
Shaperon Publishes Efficacy of Next-Generation Cancer Immunotherapy in International Journal
-
Posted on
2024-07-18
-
Views
108
-
-
14
SHAPERON EXPANDS AI PLATFORM 'AIDEN' WITH NEW CANDIDATE DISCOVERY
-
Posted on
2024-07-09
-
Views
76
-
-
13
SHAPERON ENHANCES ACCURACY OF AI TECHNOLOGY WITH "AIDEN"
-
Posted on
2024-07-02
-
Views
71
-
